Termed truncated GLI1 (tGLI1), an alternative splice variant of GLI1 [94], retains the known GLI1 functional domains, and promotes stemness gene expression (Nanog, SOX2, and OCT4) in breast cancer, ultimately leading to metastasis and drug resistance [95]. Here, GLI1 is linked to breast carcinoma.